Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.

Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Abstract Text:

    hidekazu sugasawaHidekazu Sugasawa,takashi ichikuraTakashi Ichikura,manabu kinoshitaManabu Kinoshita,satoshi onoSatoshi Ono,takashi majimaTakashi Majima,hironori tsujimotoHironori Tsujimoto,kentaro chochiKentaro Chochi,sadayuki hiroiSadayuki Hiroi,eiji takayamaEiji Takayama,daizoh saitohDaizoh Saitoh,shuhji sekiShuhji Seki,hidetaka mochizukiHidetaka Mochizuki,hidekazu sugasawaHidekazu Sugasawa,takashi ichikuraTakashi Ichikura,manabu kinoshitaManabu Kinoshita,satoshi onoSatoshi Ono,takashi majimaTakashi Majima,hironori tsujimotoHironori Tsujimoto,kentaro chochiKentaro Chochi,sadayuki hiroiSadayuki Hiroi,eiji takayamaEiji Takayama,daizoh saitohDaizoh Saitoh,shuhji sekiShuhji Seki,hidetaka mochizukiHidetaka Mochizuki,

    The level of serum CCL5, a C-C chemokine, is reportedly correlated with tumor progression in several cancers. We herein investigated the mechanisms by which CCL5 might contribute to tumor progression in gastric cancer. Serum CCL5 levels significantly correlated with tumor progression and prognosis in patients with gastric cancer. Immunohistochemistry showed that tumor-infiltrating lymphocytes expressed CCL5, while the tumor cells expressed the CCL5 receptors. Fluorescent double staining showed that tumor-infiltrating CD4+ cells rather than CD8+ cells preferentially expressed CCL5. Using gastric cancer cell lines (MKN45, KATO III), we examined CCL5 production by coculturing whole peripheral blood mononuclear cells (PBMCs), CD4+ cells, or CD8+ cells, with tumor cells. CD4+ cells cocultured with tumor cells remarkably enhanced CCL5 production in a direct cell-cell contact manner over other cocultured PBMCs, including CD8+ cells. Gastric cancer cell lines expressed CCL5 receptors and augmented their proliferation in response to CCL5 stimulation. Furthermore, we examined the effect of CCL5-treated cancer cells on the cocultured PBMCs, focusing on the CD4+/CD8+ proportion and apoptosis. Coculture of CCL5-treated gastric cancer cells with PBMCs resulted in a significant decrease in the proportion of CD8+ cells but not CD4+ cells, suggesting Fas-FasL-mediated apoptosis in CD8+ cells. In immunodeficient mice coinjected with KATO III and PBMCs, neutralization of CCL5 significantly suppressed tumor progression, resulting in a favorable outcome. In conclusion, gastric cancer cells might thus induce CD4+ T cells to secrete CCL5 and exploit it for their progression, as well as to aid in the prevention of CD8+ T cell-involved tumor elimination. (c) 2008 Wiley-Liss, Inc.

    Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Publishing Authors By Initials

    h sugasawaH Sugasawa,t ichikuraT Ichikura,m kinoshitaM Kinoshita,s onoS Ono,t majimaT Majima,h tsujimotoH Tsujimoto,k chochiK Chochi,s hiroiS Hiroi,e takayamaE Takayama,d saitohD Saitoh,s sekiS Seki,h mochizukiH Mochizuki,h sugasawaH Sugasawa,t ichikuraT Ichikura,m kinoshitaM Kinoshita,s onoS Ono,t majimaT Majima,h tsujimotoH Tsujimoto,k chochiK Chochi,s hiroiS Hiroi,e takayamaE Takayama,d saitohD Saitoh,s sekiS Seki,h mochizukiH Mochizuki,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of cancer. Journal internati

    VOLUME: 122

    Page Numbers: 2535-41

    Journal Abbreviation: Int. J. Cancer

    ISSN: 1097-0215

    DAY: 1

    MONTH: Jun

    YEAR: 2008

    Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 42124

    Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.

    AFFILIATION: Department of Surgery, National Defense Medical College, Tokorozawa, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News